Opus Genetics, Inc. (Nasdaq: IRD) (the “Company”, “Opus Genetics” or “Opus”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients ...
TrackTime, LLC v. Amazon.com Svcs. LLC, Appeal No. 2024-1102 (Fed. Cir. July 2, 2026) - In a lengthy, 26-page opinion, a panel of ...
Developers are increasingly relying on large language models (LLMs) for everyday computing tasks such as fixing bugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results